Literature DB >> 32995070

Understanding Medical Mistrust in Black Women at Risk of BRCA 1/2 Mutations.

Arnethea L Sutton1, Jun He2, Erin Tanner3, Megan C Edmonds1, Alesha Henderson1, Alejandra Hurtado de Mendoza4, Vanessa B Sheppard1.   

Abstract

The benefits of genetic counseling and testing for hereditary breast and/or ovarian cancer (HBOC) are well documented; however, Black women are less likely to use these services compared to White women. Mistrust of the medical system has been associated with Black women's use of genetic counseling and testing (GCT). However, relatively little is known about the correlates of medical mistrust in Black women at increased risk of HBOC. In this study, we examined the prevalence and predictors of medical mistrust in 94 Black women at-risk of HBOC. Most women were married (48.7%) and had at least some collegiate education (57.1%). While no predisposing characteristics were significantly related to medical mistrust, bivariate analysis indicated significant relationships between mistrust and fatalism (p=0.04), perceptions of discrimination in the healthcare setting (p=0.01), and self-efficacy in obtaining GCT (p=0.01). Multivariable analysis revealed that women who reported more discriminatory experiences and women with less confidence in obtaining GCT expressed greater medical mistrust. Multilevel approaches are needed to address psychosocial factors associated with feelings of mistrust. Future efforts must not solely focus on educating women on the importance of and need for GCT; addressing structural barriers, such as patient-provider interactions, that contribute to mistrust must become a priority.

Entities:  

Keywords:  Black Women; Genetic Counseling; Genetic Testing; Hereditary Breast/Ovarian Cancer; Medical Mistrust

Year:  2019        PMID: 32995070      PMCID: PMC7521839     

Source DB:  PubMed          Journal:  J Health Dispar Res Pract        ISSN: 2166-5222


  43 in total

1.  Interest in learning of personal genetic risk for cancer: a general population survey.

Authors:  M A Andrykowski; R K Munn; J L Studts
Journal:  Prev Med       Date:  1996 Sep-Oct       Impact factor: 4.018

2.  Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.

Authors:  K A Donovan; D C Tucker
Journal:  J Behav Med       Date:  2000-02

3.  Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.

Authors:  Darren Mays; McKane E Sharff; Tiffani A DeMarco; Bernice Williams; Beth Beck; Vanessa B Sheppard; Beth N Peshkin; Jennifer Eng-Wong; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Understanding the Influence of Stigma and Medical Mistrust on Engagement in Routine Healthcare Among Black Women Who Have Sex with Women.

Authors:  Alaina Brenick; Kelly Romano; Christopher Kegler; Lisa A Eaton
Journal:  LGBT Health       Date:  2017-02       Impact factor: 4.151

5.  Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.

Authors:  Chanita Hughes Halbert; Marc D Schwartz; Lari Wenzel; Steven Narod; Beth N Peshkin; David Cella; Caryn Lerman
Journal:  J Behav Med       Date:  2004-08

6.  Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.

Authors:  Phuong L Mai; Susan Thomas Vadaparampil; Nancy Breen; Timothy S McNeel; Louise Wideroff; Barry I Graubard
Journal:  Am J Prev Med       Date:  2014-05       Impact factor: 5.043

7.  Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women.

Authors:  Hayley S Thompson; Heiddis B Valdimarsdottir; Lina Jandorf; William Redd
Journal:  Patient Educ Couns       Date:  2003-11

8.  Mistrust of health care organizations is associated with underutilization of health services.

Authors:  Thomas A LaVeist; Lydia A Isaac; Karen Patricia Williams
Journal:  Health Serv Res       Date:  2009-09-02       Impact factor: 3.402

9.  Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.

Authors:  Leland E Hull; Jennifer S Haas; Steven R Simon
Journal:  Am J Prev Med       Date:  2017-12-11       Impact factor: 5.043

10.  Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer.

Authors:  Veronica I Lagos; Martin A Perez; Charité N Ricker; Kathleen R Blazer; Nydia M Santiago; Nancy Feldman; Lori Viveros; Jeffrey N Weitzel
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

View more
  1 in total

1.  Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.

Authors:  Julianne M O'Daniel; Sara Ackerman; Lauren R Desrosiers; Shannon Rego; Sara J Knight; Lonna Mollison; Grace Byfield; Katherine P Anderson; Maria I Danila; Carol R Horowitz; Galen Joseph; Grace Lamoure; Nangel M Lindberg; Carmit K McMullen; Kathleen F Mittendorf; Michelle A Ramos; Mimsie Robinson; Catherine Sillari; Ebony B Madden
Journal:  Genet Med       Date:  2022-02-25       Impact factor: 8.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.